For-IC Capsule
strip of 10.0 capsules.Prescription required
About this product:
| Salt Composition: | Pentosan polysulfate sodium (100mg) |
| Manufacturer: | Cipla Ltd |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
For-IC Capsule is used for treating bladder pain or discomfort associated with interstitial cystitis (painful bladder syndrome). For-IC Capsule is advised to take it in a dose and duration as per prescription. It should be taken on an empty stomach at least an hour before having a meal. Swallow the medicine as a whole without crushing or chewing it. You should not stop taking the medicine without consulting the doctor as it may lead to the worsening of your symptoms. The course of the treatment should be completed for better efficacy of the medicine.
For-IC Capsule binds to the urinary bladder wall and prevents the irritating chemicals in the urine from coming in contact with the bladder wall.
Can the use of For-IC Capsule increase the risk of bleeding?
Yes, For-IC Capsule contains a weak anticoagulant effect, which may increase your risk of bleeding. Always be cautious while performing activities that may cause injury or bleeding. Report any abnormal bruising or bleeding or blood in stool to your doctor immediately.
Is For-IC Capsule a steroid?
No, For-IC Capsule is not a steroid. It is used for the treatment of interstitial cystitis (also known as bladder pain syndrome). This condition can cause sores on the inner lining of the urinary bladder, accompanied by tiny bleeds, and patients often complain of pain and a frequent urge to urinate.
How long does it take for For-IC Capsule to start working?
Generally, it takes 3 to 6 months of continuous therapy to experience some benefit or improvement. However, the time required to see effects varies as For-IC Capsule is recommended for long-term use to achieve effective clinical benefits. After 3 months of treatment, patients are reassessed to analyze if the medication can be continued longer without experiencing any side effects.
Who should be cautious when starting For-IC Capsule?
Do not take this medication without consulting your doctor. Inform your physician if you have a disease that you are already treating with blood thinners like warfarin, heparin, aspirin, etc., as taking For-IC Capsule may increase the risk of bleeding. Additionally, pregnant women and patients with liver or kidney problems should exercise caution while using this medicine.
How should I take For-IC Capsule?
For-IC Capsule should be taken in the prescribed dosage by your doctor. Take the entire capsule at least 1 hour before meals or 2 hours after meals with a glass of water.
Does For-IC Capsule need to be refrigerated?
No, For-IC Capsule does not require refrigeration. It comes in capsule form and can be stored at room temperature (below 30°C). Ensure the bottle is tightly closed to protect the medication from moisture. Use the medicine within the specified time after opening the pack; it's essential to discard and stop using the medicine after its expiry date.
Take this medicine in the dose and duration as advised by your doctor. For-IC Capsule is to be taken empty stomach.
- You have been prescribed For-IC Capsule for relieving bladder pain or discomfort associated with interstitial cystitis.
- Take it at least 1 hour before meals or 2 hours after meals.
- It may take 12-16 weeks of treatment before any effect is seen. Keep taking it as prescribed.
- Inform your doctor if you will be undergoing any surgery or are taking anticoagulants such as warfarin sodium, heparin, or high doses of aspirin as For-IC Capsule may increase the risk of bleeding.
- Hair loss
- Diarrhea
- Nausea
- Rash
- Headache
Alcohol
It is not known whether it is safe to consume alcohol with For-IC Capsule. Please consult your doctor.
Breastfeed
Information regarding the use of For-IC Capsule during breastfeeding is not available. Please consult your doctor.
Pregnancy
For-IC Capsule is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
